NPC1
NPC1 (NPC intracellular cholesterol transporter 1, also known as SLC65A1) is a large membrane protein of late endosomes and lysosomes that mediates intracellular cholesterol trafficking. Defects in the NPC1 gene cause Niemann-Pick type C disease, and the protein also acts as an endosomal entry receptor for ebolavirus. Browse Assay Genie's current range of NPC1 research reagents below, or read on for the biology behind the target.
NPC1 resides in the limiting membrane of endosomes and lysosomes and mediates intracellular cholesterol trafficking. Cholesterol binds to its N-terminal domain. The protein transports low-density lipoproteins to late endosomal and lysosomal compartments, where they are hydrolysed and released as free cholesterol. In a separate, microbial-infection context, NPC1 acts as an endosomal entry receptor for ebolavirus.
The NPC1 protein is predicted to have a cytoplasmic C-terminus, 13 transmembrane domains and three large loops in the lumen of the endosome, the last of which sits at the N-terminus. It belongs to the patched family. The HGNC places the NPC1 gene in solute carrier family 65, and SLC65A1 is a recognised alias. Researchers studying the mouse counterpart will find it as Npc1.
The gene takes its name from Niemann-Pick disease, type C1. Defects in the NPC1 gene cause Niemann-Pick type C disease, a rare autosomal recessive neurodegenerative disorder. The disease is characterised by over-accumulation of cholesterol and glycosphingolipids in late endosomal and lysosomal compartments. This makes NPC1 a central reference point for work on lysosomal lipid handling, and its role in ebolavirus entry gives it relevance in virology as well.
NPC1 mediates intracellular cholesterol trafficking, binding cholesterol through its N-terminal domain and delivering lipoprotein-derived cholesterol from late endosomes and lysosomes.
Defects in NPC1 cause Niemann-Pick type C, a rare autosomal recessive neurodegenerative disorder marked by cholesterol and glycosphingolipid accumulation.
NPC1 is located in the limiting membrane of late endosomes and lysosomes, where it helps release free cholesterol from hydrolysed low-density lipoproteins.
NPC1 acts as an endosomal entry receptor for ebolavirus, linking this lysosomal protein to studies of viral infection.
NPC1 is a late endosome and lysosome membrane protein that mediates intracellular cholesterol trafficking, binding cholesterol through its N-terminal domain. It transports low-density lipoproteins to late endosomal and lysosomal compartments, where they are hydrolysed and released as free cholesterol. It also serves as an endosomal entry receptor for ebolavirus.
The approved name is NPC intracellular cholesterol transporter 1. The previous name was Niemann-Pick disease, type C1, and the alias SLC65A1 reflects its HGNC assignment to solute carrier family 65. UniProt also classes the protein within the patched family.
Defects in the NPC1 gene cause Niemann-Pick type C disease, a rare autosomal recessive neurodegenerative disorder. Cholesterol and glycosphingolipids over-accumulate in late endosomal and lysosomal compartments. The mouse ortholog is Npc1; check the datasheet of any product for its validated reactivity.
Other NPC-family cholesterol transport proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O15118; product specifications from Assay Genie datasheets.